CYH - Community Health Systems Inc P/S Multiple

Brandmark of Community Health Corp (CYH)

Community Health Systems, a leading US hospital operator, is reducing its debt through asset sales and cost optimization. The company's price/sales multiple confirms this trend, where the value of 0.00 reflects the current valuation status. However, the business relies on intensive manual labor from medical staff, while a high debt load coupled with expensive loans and low margins create significant financial pressure.

CYH (Community Health Systems, Inc.) P/S Multiple history from 07/04/2022 to 11/13/2026

Community Health Systems Inc (CYH) - metric breakdowns and financial figures

- market price and analyst price targets:
Summary company analytics:chs.net, CYH
Brand item of Community Health Systems, Inc.

For Community Health Systems (CYH), which faces pricing constraints due to strict Medicare and insurance company tariffs, this indicator reflects the market value of every dollar of revenue generated. By analyzing the price-to-sales ratio, an investor determines the premium paid for operating turnover, allowing for a correlation between current market capitalization and the actual volume of medical services provided within a low-margin business environment.

Competing companies

Market Cap to Revenue hcahealthcare.com HCA|Tenet Healthcare Corporation - Market Cap to Revenue|P/S Multiple Fresenius Medical Care AG FMS|SOLV - Price-to-Revenue Ratio|EHC (Encompass) - Market Cap to Revenue Ratio|UHS: P/S Multiple|DVA - Price-to-Revenue Coefficient|Market Cap to Revenue RDNT|OPCH (Option Care) - Market Cap to Sales Volume|Market Cap to Revenue SGRY (Surgery Partners Corp)|PINC - Price to Sales|National Vision Holdings - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio PGNY|Ardent Health Partners - P/S Multiple|Market Capitalization-to-Revenue Ratio SEM (Select Medical Corporation)|ASTH: P/S Multiple|Price to Sales MEDNAX (MD)|USPH (US Physical Therapy) - P/S Multiple|P/S Multiple pennantgroup.com|Price-to-Revenue Ratio Organogenesis (ORGO)|Price-to-Revenue Ratio NUTX (Nutex Health Inc)|Auna Health - Market Cap to Revenue|Market Cap to Sales Volume SBC (SBC Medical Group Holdings)|Evolus, Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio SKIN (The Beauty Health)|MDWD (mediwound.com) - Market Cap to Revenue|Biote - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio The Joint Corporation|DocGo, Inc (DCGO) - Price-to-Revenue Coefficient|Market Cap to Revenue PIII (P3 Health Partners Inc.)|GANX - Price to Sales|Price-to-Revenue Ratio EUDA Health Holdings Limited EUDA|Price-to-Revenue Coefficient Basel Medical (BMGL)|CLGN: Market Cap to Revenue|Cuprina Holdings Limited - Market Cap to Sales Volume|CCM: P/S Multiple|Price to Sales ashs.com (AMS)|Price-to-Revenue Ratio MEDIROM Healthcare Group|Market Cap to Revenue Avalon GloboCare Corporation (ALBT)|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|Price-to-Revenue Coefficient Carmell Corp|P/S Multiple NIVF (NewGenIvf Group Limited)|ATIP - Market Cap to Revenue|CMAX: Market Cap to Revenue|Price to Sales Kindly MD Inc|MODV: P/S Multiple|Novo Integrated Sciences Corp - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SSY|BACK (imacholdings.comm) - Market Cap to Sales Volume